These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12834011)

  • 1. Kava extracts: safety and risks including rare hepatotoxicity.
    Teschke R; Gaus W; Loew D
    Phytomedicine; 2003; 10(5):440-6. PubMed ID: 12834011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kava hepatotoxicity--a clinical review.
    Teschke R
    Ann Hepatol; 2010; 9(3):251-65. PubMed ID: 20720265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases.
    Teschke R; Schwarzenboeck A; Hennermann KH
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1182-93. PubMed ID: 18989142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kava hepatotoxicity: regulatory data selection and causality assessment.
    Teschke R; Wolff A
    Dig Liver Dis; 2009 Dec; 41(12):891-901. PubMed ID: 19477698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures.
    Teschke R; Genthner A; Wolff A
    J Ethnopharmacol; 2009 Jun; 123(3):378-84. PubMed ID: 19501269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence.
    Teschke R; Qiu SX; Xuan TD; Lebot V
    Phytother Res; 2011 Sep; 25(9):1263-74. PubMed ID: 21442674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kava hepatotoxicity: a European view.
    Teschke R; Schwarzenboeck A; Akinci A
    N Z Med J; 2008 Oct; 121(1283):90-8. PubMed ID: 18841189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kava hepatotoxicity solution: A six-point plan for new kava standardization.
    Teschke R; Sarris J; Lebot V
    Phytomedicine; 2011 Jan; 18(2-3):96-103. PubMed ID: 21112196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kava, kavapyrones and toxic liver injury].
    Teschke R
    Z Gastroenterol; 2003 May; 41(5):395-404. PubMed ID: 12772052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited.
    Teschke R; Sarris J; Schweitzer I
    Br J Clin Pharmacol; 2012 Feb; 73(2):170-4. PubMed ID: 21801196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?
    Teschke R; Wolff A
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):1-7. PubMed ID: 20854865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contaminant hepatotoxins as culprits for kava hepatotoxicity--fact or fiction?
    Teschke R; Sarris J; Lebot V
    Phytother Res; 2013 Mar; 27(3):472-4. PubMed ID: 22585547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation and the use of KAVA: Case report.
    Becker MW; Lourençone EMS; De Mello AF; Branco A; Filho EMR; Blatt CR; Mallmann CA; Schneider M; Caregnato RCA; Blatt CR
    Phytomedicine; 2019 Mar; 56():21-26. PubMed ID: 30668342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kava kava: examining new reports of toxicity.
    Clouatre DL
    Toxicol Lett; 2004 Apr; 150(1):85-96. PubMed ID: 15068826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kava: herbal panacea or liver poison?
    Moulds RF; Malani J
    Med J Aust; 2003 May; 178(9):451-3. PubMed ID: 12720513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment.
    Teschke R; Fuchs J; Bahre R; Genthner A; Wolff A
    J Clin Pharm Ther; 2010 Oct; 35(5):545-63. PubMed ID: 20831679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kava hepatotoxicity: pathogenetic aspects and prospective considerations.
    Teschke R
    Liver Int; 2010 Oct; 30(9):1270-9. PubMed ID: 20630022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits.
    Teschke R; Qiu SX; Lebot V
    Dig Liver Dis; 2011 Sep; 43(9):676-81. PubMed ID: 21377431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of kava hepatotoxicity and the FDA consumer advisory.
    Teschke R; Schulze J
    JAMA; 2010 Nov; 304(19):2174-5. PubMed ID: 21081732
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum).
    Jhoo JW; Freeman JP; Heinze TM; Moody JD; Schnackenberg LK; Beger RD; Dragull K; Tang CS; Ang CY
    J Agric Food Chem; 2006 Apr; 54(8):3157-62. PubMed ID: 16608246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.